

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.72841393 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.45752257 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.45752257 |
| 4 | ethanol oxidation (GO:0006069) | 4.18458418 |
| 5 | regulation of early endosome to late endosome transport (GO:2000641) | 4.17447649 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 4.11741046 |
| 7 | barbed-end actin filament capping (GO:0051016) | 4.11376398 |
| 8 | lysine catabolic process (GO:0006554) | 4.06306303 |
| 9 | lysine metabolic process (GO:0006553) | 4.06306303 |
| 10 | focal adhesion assembly (GO:0048041) | 3.93426697 |
| 11 | cell-substrate adherens junction assembly (GO:0007045) | 3.93426697 |
| 12 | urea cycle (GO:0000050) | 3.92847133 |
| 13 | urea metabolic process (GO:0019627) | 3.92847133 |
| 14 | cysteine metabolic process (GO:0006534) | 3.91509395 |
| 15 | amyloid precursor protein catabolic process (GO:0042987) | 3.90809325 |
| 16 | stress fiber assembly (GO:0043149) | 3.86417264 |
| 17 | pinocytosis (GO:0006907) | 3.85986607 |
| 18 | adherens junction assembly (GO:0034333) | 3.84713011 |
| 19 | cell-substrate junction assembly (GO:0007044) | 3.75476883 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 3.74531254 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.72433651 |
| 22 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.68393668 |
| 23 | axon extension involved in axon guidance (GO:0048846) | 3.68393668 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 3.64352739 |
| 25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.44205852 |
| 26 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.40448984 |
| 27 | protein retention in ER lumen (GO:0006621) | 3.39940738 |
| 28 | growth hormone receptor signaling pathway (GO:0060396) | 3.37839291 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 3.37097173 |
| 30 | nuclear pore complex assembly (GO:0051292) | 3.33339430 |
| 31 | glyoxylate metabolic process (GO:0046487) | 3.31828973 |
| 32 | regulation of chromatin binding (GO:0035561) | 3.28823751 |
| 33 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.28134613 |
| 34 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.27584982 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26128250 |
| 36 | positive regulation of fatty acid oxidation (GO:0046321) | 3.26107854 |
| 37 | cellular protein complex localization (GO:0034629) | 3.23739592 |
| 38 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.22462683 |
| 39 | regulation of sister chromatid cohesion (GO:0007063) | 3.22171854 |
| 40 | skin morphogenesis (GO:0043589) | 3.20211049 |
| 41 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.17865359 |
| 42 | ethanol metabolic process (GO:0006067) | 3.15098943 |
| 43 | hemidesmosome assembly (GO:0031581) | 3.12727515 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.10035407 |
| 45 | embryonic process involved in female pregnancy (GO:0060136) | 3.07115968 |
| 46 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.05501468 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02482460 |
| 48 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.01701952 |
| 49 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.99899928 |
| 50 | epithelial cell-cell adhesion (GO:0090136) | 2.99895167 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 2.95031589 |
| 52 | cell adhesion mediated by integrin (GO:0033627) | 2.94531258 |
| 53 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.92949475 |
| 54 | regulation of fibrinolysis (GO:0051917) | 2.91961831 |
| 55 | protein insertion into membrane (GO:0051205) | 2.91803693 |
| 56 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.90432992 |
| 57 | acetyl-CoA metabolic process (GO:0006084) | 2.90235595 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.88943515 |
| 59 | L-phenylalanine catabolic process (GO:0006559) | 2.88943515 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 2.88834710 |
| 61 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.88278566 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 2.87538752 |
| 63 | cortical actin cytoskeleton organization (GO:0030866) | 2.87015978 |
| 64 | DNA unwinding involved in DNA replication (GO:0006268) | 2.86120335 |
| 65 | cellular response to growth hormone stimulus (GO:0071378) | 2.84832815 |
| 66 | hypotonic response (GO:0006971) | 2.82905952 |
| 67 | apoptotic cell clearance (GO:0043277) | 2.80495797 |
| 68 | activation of Rac GTPase activity (GO:0032863) | 2.80120042 |
| 69 | protein complex localization (GO:0031503) | 2.79797627 |
| 70 | negative regulation of cell size (GO:0045792) | 2.78553944 |
| 71 | L-phenylalanine metabolic process (GO:0006558) | 2.77529395 |
| 72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.77529395 |
| 73 | homocysteine metabolic process (GO:0050667) | 2.77031964 |
| 74 | phospholipid homeostasis (GO:0055091) | 2.75594550 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 2.74803068 |
| 76 | endodermal cell differentiation (GO:0035987) | 2.73176911 |
| 77 | membrane raft organization (GO:0031579) | 2.72944580 |
| 78 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.72515267 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.71551445 |
| 80 | fatty acid transmembrane transport (GO:1902001) | 2.69305532 |
| 81 | hippo signaling (GO:0035329) | 2.68379707 |
| 82 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.67695984 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67550069 |
| 84 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66742636 |
| 85 | piRNA metabolic process (GO:0034587) | 2.66481732 |
| 86 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65440052 |
| 87 | tryptophan catabolic process (GO:0006569) | 2.65398012 |
| 88 | indole-containing compound catabolic process (GO:0042436) | 2.65398012 |
| 89 | indolalkylamine catabolic process (GO:0046218) | 2.65398012 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 2.64715081 |
| 91 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.64616438 |
| 92 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.64204271 |
| 93 | negative regulation of cholesterol transport (GO:0032375) | 2.63686192 |
| 94 | negative regulation of sterol transport (GO:0032372) | 2.63686192 |
| 95 | nuclear pore organization (GO:0006999) | 2.63536249 |
| 96 | flavonoid metabolic process (GO:0009812) | 2.63374131 |
| 97 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.63310383 |
| 98 | glycine metabolic process (GO:0006544) | 2.63113654 |
| 99 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.62200411 |
| 100 | basement membrane organization (GO:0071711) | 2.62148940 |
| 101 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.60849358 |
| 102 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.60674910 |
| 103 | mitochondrial fusion (GO:0008053) | 2.59927374 |
| 104 | midgut development (GO:0007494) | 2.59851556 |
| 105 | macroautophagy (GO:0016236) | 2.59558682 |
| 106 | response to laminar fluid shear stress (GO:0034616) | 2.59156425 |
| 107 | metaphase plate congression (GO:0051310) | 2.58825482 |
| 108 | kynurenine metabolic process (GO:0070189) | 2.57883174 |
| 109 | regulation of translational fidelity (GO:0006450) | 2.57817817 |
| 110 | primary alcohol catabolic process (GO:0034310) | 2.57563990 |
| 111 | maternal placenta development (GO:0001893) | 2.55431571 |
| 112 | positive regulation of nuclease activity (GO:0032075) | 2.55091134 |
| 113 | regulation of centriole replication (GO:0046599) | 2.54554462 |
| 114 | spindle assembly involved in mitosis (GO:0090307) | 2.54442475 |
| 115 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.53945471 |
| 116 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.53945471 |
| 117 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.53945471 |
| 118 | carnitine shuttle (GO:0006853) | 2.53925148 |
| 119 | regulation of translational termination (GO:0006449) | 2.53601698 |
| 120 | mitotic chromosome condensation (GO:0007076) | 2.53182694 |
| 121 | tryptophan metabolic process (GO:0006568) | 2.53178907 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53178553 |
| 123 | modulation by symbiont of host cellular process (GO:0044068) | 2.52681498 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 2.52544649 |
| 125 | regulation of RNA export from nucleus (GO:0046831) | 2.52527580 |
| 126 | one-carbon metabolic process (GO:0006730) | 2.52160220 |
| 127 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.51137883 |
| 128 | hyaluronan catabolic process (GO:0030214) | 2.51086251 |
| 129 | mRNA stabilization (GO:0048255) | 2.51010993 |
| 130 | RNA stabilization (GO:0043489) | 2.51010993 |
| 131 | complement activation, alternative pathway (GO:0006957) | 2.50510168 |
| 132 | regulation of protein activation cascade (GO:2000257) | 2.49870901 |
| 133 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.48645737 |
| 134 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.48285641 |
| 135 | reverse cholesterol transport (GO:0043691) | 2.46782326 |
| 136 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.46764068 |
| 137 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.46541503 |
| 138 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.45966030 |
| 139 | phospholipid efflux (GO:0033700) | 2.45926030 |
| 140 | short-chain fatty acid metabolic process (GO:0046459) | 2.45915264 |
| 141 | apoptotic process involved in morphogenesis (GO:0060561) | 2.45605741 |
| 142 | bile acid biosynthetic process (GO:0006699) | 2.44746169 |
| 143 | aspartate family amino acid catabolic process (GO:0009068) | 2.44691506 |
| 144 | cortical cytoskeleton organization (GO:0030865) | 2.44624034 |
| 145 | activation of MAPKKK activity (GO:0000185) | 2.44563986 |
| 146 | positive regulation of receptor recycling (GO:0001921) | 2.44238615 |
| 147 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.43684799 |
| 148 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.43499111 |
| 149 | protein carboxylation (GO:0018214) | 2.43499111 |
| 150 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.43481016 |
| 151 | positive regulation of myotube differentiation (GO:0010831) | 2.42572307 |
| 152 | ER-nucleus signaling pathway (GO:0006984) | 2.42194161 |
| 153 | response to nitrosative stress (GO:0051409) | 2.41837143 |
| 154 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.41710885 |
| 155 | pore complex assembly (GO:0046931) | 2.41351614 |
| 156 | regulation of fatty acid oxidation (GO:0046320) | 2.41324644 |
| 157 | gene silencing by RNA (GO:0031047) | 2.41320720 |
| 158 | negative regulation of anoikis (GO:2000811) | 2.41181499 |
| 159 | vesicle coating (GO:0006901) | 2.40978492 |
| 160 | 2-oxoglutarate metabolic process (GO:0006103) | 2.40503625 |
| 161 | cellular glucuronidation (GO:0052695) | 2.40039989 |
| 162 | negative regulation of lipid transport (GO:0032369) | 2.39055372 |
| 163 | positive regulation of mitochondrial fission (GO:0090141) | 2.38847765 |
| 164 | regulation of cholesterol storage (GO:0010885) | 2.38662878 |
| 165 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.38600590 |
| 166 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38130255 |
| 167 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.37639207 |
| 168 | pentose-phosphate shunt (GO:0006098) | 2.37630201 |
| 169 | fatty acid oxidation (GO:0019395) | 2.37530290 |
| 170 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.37276443 |
| 171 | carnitine metabolic process (GO:0009437) | 2.36325831 |
| 172 | cellular modified amino acid catabolic process (GO:0042219) | 2.35594980 |
| 173 | negative regulation of fatty acid transport (GO:2000192) | 2.35560532 |
| 174 | type B pancreatic cell proliferation (GO:0044342) | 2.35379800 |
| 175 | membrane protein ectodomain proteolysis (GO:0006509) | 2.35343992 |
| 176 | regulation of anoikis (GO:2000209) | 2.35060831 |
| 177 | protein-lipid complex assembly (GO:0065005) | 2.34598601 |
| 178 | actin filament bundle assembly (GO:0051017) | 2.34096058 |
| 179 | actin filament bundle organization (GO:0061572) | 2.34096058 |
| 180 | regulation of nuclease activity (GO:0032069) | 2.29039996 |
| 181 | protein hydroxylation (GO:0018126) | 2.28588662 |
| 182 | protein export from nucleus (GO:0006611) | 2.27565754 |
| 183 | positive regulation of protein export from nucleus (GO:0046827) | 2.24951994 |
| 184 | embryo implantation (GO:0007566) | 2.24535310 |
| 185 | paraxial mesoderm development (GO:0048339) | 2.22970295 |
| 186 | negative regulation of necroptotic process (GO:0060546) | 2.22684728 |
| 187 | cellular response to unfolded protein (GO:0034620) | 2.22152226 |
| 188 | semaphorin-plexin signaling pathway (GO:0071526) | 2.22144999 |
| 189 | peptidyl-proline hydroxylation (GO:0019511) | 2.20985334 |
| 190 | protein localization to microtubule (GO:0035372) | 2.20970021 |
| 191 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.19837419 |
| 192 | endocytic recycling (GO:0032456) | 2.19637783 |
| 193 | negative regulation of DNA repair (GO:0045738) | 2.19191929 |
| 194 | cellular hyperosmotic response (GO:0071474) | 2.18919191 |
| 195 | peptidyl-lysine dimethylation (GO:0018027) | 2.18749424 |
| 196 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.17899392 |
| 197 | low-density lipoprotein particle clearance (GO:0034383) | 2.16700869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.14999396 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47820816 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.13272821 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.87271639 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.71017399 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.47932269 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.40684483 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.34332297 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.00652327 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.76574441 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.51686065 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.44044672 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43967472 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.35108594 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34760061 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20386442 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.08629290 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.95702893 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95112454 |
| 20 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.85496455 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80045367 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.75464440 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70297285 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.66533989 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.65469452 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64402097 |
| 27 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.60078333 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58480035 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55135983 |
| 30 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54433410 |
| 31 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53309404 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51030859 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49946130 |
| 34 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49329660 |
| 35 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.49213965 |
| 36 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48923030 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.48337372 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.48337372 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46730123 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44882752 |
| 41 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44156491 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43515928 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42736715 |
| 44 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.41951823 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40206183 |
| 46 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40107438 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.39744742 |
| 48 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.39150473 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37852436 |
| 50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37435701 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36500677 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34261962 |
| 53 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.32321736 |
| 54 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32008847 |
| 55 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30691604 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28917311 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28087021 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26840392 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26659661 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25842658 |
| 61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24750345 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24630546 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23909485 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23207784 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22795596 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22236116 |
| 67 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.20994279 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.20929751 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20710978 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19757570 |
| 71 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.19412528 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19352985 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18574142 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18457497 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18420391 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17730279 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17195524 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14591610 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14285136 |
| 80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.13674229 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12980425 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12372305 |
| 83 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.11679540 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.10526186 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09133648 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08941359 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08027369 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07497035 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07362247 |
| 90 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07335500 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07328047 |
| 92 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.06776183 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06652532 |
| 94 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06587095 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06142457 |
| 96 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06035727 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05938165 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05715959 |
| 99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05341649 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05341649 |
| 101 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04518434 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04474602 |
| 103 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04400094 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04363294 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04288990 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04218796 |
| 107 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04091503 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03293543 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02270125 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01092486 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00610782 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00516315 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00208113 |
| 114 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99845563 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99605919 |
| 116 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99099182 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98280942 |
| 118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98252611 |
| 119 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98172236 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96894596 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96632399 |
| 122 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.94859782 |
| 123 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.94721372 |
| 124 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94393017 |
| 125 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93915598 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93208430 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91279200 |
| 128 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90486233 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90477278 |
| 130 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90294723 |
| 131 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.89979520 |
| 132 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88847529 |
| 133 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88189836 |
| 134 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88188369 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87896994 |
| 136 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84537688 |
| 137 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.84151861 |
| 138 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83765143 |
| 139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83579659 |
| 140 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80892520 |
| 141 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80534934 |
| 142 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.80427873 |
| 143 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80146727 |
| 144 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79496671 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78939169 |
| 146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78757884 |
| 147 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78525028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.05227163 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.72244713 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.00419754 |
| 4 | MP0005365_abnormal_bile_salt | 2.93750422 |
| 5 | MP0010030_abnormal_orbit_morphology | 2.88311830 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.64890663 |
| 7 | MP0002102_abnormal_ear_morphology | 2.58171197 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.47525150 |
| 9 | MP0009840_abnormal_foam_cell | 2.46468215 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.44605766 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.34071010 |
| 12 | MP0003252_abnormal_bile_duct | 2.24687888 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.24605409 |
| 14 | MP0005451_abnormal_body_composition | 2.24390125 |
| 15 | MP0003091_abnormal_cell_migration | 2.20002364 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 2.12206588 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.11624166 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02667927 |
| 19 | MP0003950_abnormal_plasma_membrane | 1.92906832 |
| 20 | MP0008260_abnormal_autophagy | 1.90552611 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.81336883 |
| 22 | MP0004272_abnormal_basement_membrane | 1.76980061 |
| 23 | MP0000751_myopathy | 1.76099533 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.73932181 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.73407256 |
| 26 | MP0005408_hypopigmentation | 1.64755151 |
| 27 | MP0009053_abnormal_anal_canal | 1.55741286 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.55720600 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.54931951 |
| 30 | MP0004858_abnormal_nervous_system | 1.53925254 |
| 31 | MP0005187_abnormal_penis_morphology | 1.49886801 |
| 32 | MP0003279_aneurysm | 1.48510686 |
| 33 | MP0003646_muscle_fatigue | 1.44832349 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.43755890 |
| 35 | MP0003303_peritoneal_inflammation | 1.42237080 |
| 36 | MP0003941_abnormal_skin_development | 1.41499091 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.40947078 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.40291516 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.40204532 |
| 40 | MP0004233_abnormal_muscle_weight | 1.40162359 |
| 41 | MP0001984_abnormal_olfaction | 1.39971240 |
| 42 | MP0000858_altered_metastatic_potential | 1.39763075 |
| 43 | MP0000747_muscle_weakness | 1.38395772 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.32478678 |
| 45 | MP0006054_spinal_hemorrhage | 1.32446305 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.32204278 |
| 47 | MP0000609_abnormal_liver_physiology | 1.31299753 |
| 48 | MP0001958_emphysema | 1.31194255 |
| 49 | MP0001849_ear_inflammation | 1.30096043 |
| 50 | MP0005499_abnormal_olfactory_system | 1.30064936 |
| 51 | MP0005394_taste/olfaction_phenotype | 1.30064936 |
| 52 | MP0001915_intracranial_hemorrhage | 1.29050159 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.27569075 |
| 54 | MP0000537_abnormal_urethra_morphology | 1.27187347 |
| 55 | MP0005501_abnormal_skin_physiology | 1.26372252 |
| 56 | MP0005409_darkened_coat_color | 1.23814688 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.23584810 |
| 58 | MP0003718_maternal_effect | 1.20207058 |
| 59 | MP0000767_abnormal_smooth_muscle | 1.19540000 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.18682185 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.15065263 |
| 62 | MP0004130_abnormal_muscle_cell | 1.14867028 |
| 63 | MP0005621_abnormal_cell_physiology | 1.14410446 |
| 64 | MP0001346_abnormal_lacrimal_gland | 1.13537246 |
| 65 | MP0000579_abnormal_nail_morphology | 1.11444724 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.11334338 |
| 67 | MP0005023_abnormal_wound_healing | 1.10920129 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.10762344 |
| 69 | MP0005083_abnormal_biliary_tract | 1.10357552 |
| 70 | MP0010630_abnormal_cardiac_muscle | 1.08698185 |
| 71 | MP0001661_extended_life_span | 1.07112787 |
| 72 | MP0000749_muscle_degeneration | 1.06941831 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.06735780 |
| 74 | MP0002233_abnormal_nose_morphology | 1.04976980 |
| 75 | MP0004947_skin_inflammation | 1.04273595 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.03554022 |
| 77 | MP0000569_abnormal_digit_pigmentation | 1.03521885 |
| 78 | MP0003111_abnormal_nucleus_morphology | 1.03213928 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.02833926 |
| 80 | MP0009115_abnormal_fat_cell | 1.02245813 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.01680467 |
| 82 | MP0001730_embryonic_growth_arrest | 1.01399646 |
| 83 | MP0003448_altered_tumor_morphology | 1.01242901 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.99344926 |
| 85 | MP0003828_pulmonary_edema | 0.99246294 |
| 86 | MP0002249_abnormal_larynx_morphology | 0.99148298 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.98976165 |
| 88 | MP0000566_synostosis | 0.98947777 |
| 89 | MP0006138_congestive_heart_failure | 0.98001245 |
| 90 | MP0003329_amyloid_beta_deposits | 0.97464275 |
| 91 | MP0000598_abnormal_liver_morphology | 0.97432786 |
| 92 | MP0004510_myositis | 0.96554170 |
| 93 | MP0000750_abnormal_muscle_regeneration | 0.96371154 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.96180094 |
| 95 | MP0003315_abnormal_perineum_morphology | 0.94622286 |
| 96 | MP0009672_abnormal_birth_weight | 0.94123811 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.93650166 |
| 98 | MP0000733_abnormal_muscle_development | 0.93430977 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.91761764 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91649056 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.91648754 |
| 102 | MP0005275_abnormal_skin_tensile | 0.90147784 |
| 103 | MP0009278_abnormal_bone_marrow | 0.89979259 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.89610867 |
| 105 | MP0002938_white_spotting | 0.88651080 |
| 106 | MP0002269_muscular_atrophy | 0.87567071 |
| 107 | MP0002160_abnormal_reproductive_system | 0.87463434 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.87190282 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.87113218 |
| 110 | MP0005380_embryogenesis_phenotype | 0.86696154 |
| 111 | MP0001672_abnormal_embryogenesis/_devel | 0.86696154 |
| 112 | MP0010307_abnormal_tumor_latency | 0.86180068 |
| 113 | MP0003984_embryonic_growth_retardation | 0.85471718 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.85391859 |
| 115 | MP0002396_abnormal_hematopoietic_system | 0.85329759 |
| 116 | MP0002118_abnormal_lipid_homeostasis | 0.85150982 |
| 117 | MP0000428_abnormal_craniofacial_morphol | 0.84966855 |
| 118 | * MP0002080_prenatal_lethality | 0.84275766 |
| 119 | MP0001293_anophthalmia | 0.84274535 |
| 120 | MP0000762_abnormal_tongue_morphology | 0.82801869 |
| 121 | MP0002132_abnormal_respiratory_system | 0.82414524 |
| 122 | MP0002088_abnormal_embryonic_growth/wei | 0.82198430 |
| 123 | MP0002098_abnormal_vibrissa_morphology | 0.82189682 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82057883 |
| 125 | MP0003186_abnormal_redox_activity | 0.81469542 |
| 126 | MP0001697_abnormal_embryo_size | 0.81168115 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.80979345 |
| 128 | MP0002932_abnormal_joint_morphology | 0.79850368 |
| 129 | MP0000377_abnormal_hair_follicle | 0.79546636 |
| 130 | MP0000604_amyloidosis | 0.79487276 |
| 131 | MP0005330_cardiomyopathy | 0.78983351 |
| 132 | MP0001216_abnormal_epidermal_layer | 0.78954186 |
| 133 | MP0005384_cellular_phenotype | 0.78721001 |
| 134 | MP0002086_abnormal_extraembryonic_tissu | 0.78105767 |
| 135 | MP0005332_abnormal_amino_acid | 0.77761997 |
| 136 | MP0002796_impaired_skin_barrier | 0.77150985 |
| 137 | MP0004036_abnormal_muscle_relaxation | 0.77036705 |
| 138 | MP0002128_abnormal_blood_circulation | 0.77016341 |
| 139 | MP0002060_abnormal_skin_morphology | 0.77015113 |
| 140 | MP0003693_abnormal_embryo_hatching | 0.75920285 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.75492360 |
| 142 | MP0005397_hematopoietic_system_phenotyp | 0.75492360 |
| 143 | MP0003077_abnormal_cell_cycle | 0.74721870 |
| 144 | MP0010678_abnormal_skin_adnexa | 0.72997561 |
| 145 | MP0000490_abnormal_crypts_of | 0.72749015 |
| 146 | MP0005165_increased_susceptibility_to | 0.72693852 |
| 147 | MP0000343_altered_response_to | 0.72358492 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.71865145 |
| 149 | MP0001243_abnormal_dermal_layer | 0.71585512 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.70641959 |
| 151 | MP0001299_abnormal_eye_distance/ | 0.70577224 |
| 152 | MP0005623_abnormal_meninges_morphology | 0.70301002 |
| 153 | MP0005464_abnormal_platelet_physiology | 0.69872874 |
| 154 | MP0001853_heart_inflammation | 0.69720963 |
| 155 | MP0000350_abnormal_cell_proliferation | 0.69655685 |
| 156 | MP0000678_abnormal_parathyroid_gland | 0.69591873 |
| 157 | MP0002092_abnormal_eye_morphology | 0.68500712 |
| 158 | MP0008007_abnormal_cellular_replicative | 0.68343625 |
| 159 | MP0005395_other_phenotype | 0.68261146 |
| 160 | MP0005503_abnormal_tendon_morphology | 0.67984254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.58863904 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.05717092 |
| 3 | Cortical dysplasia (HP:0002539) | 3.83052576 |
| 4 | Renovascular hypertension (HP:0100817) | 3.50917687 |
| 5 | Hallux valgus (HP:0001822) | 3.48121285 |
| 6 | Deviation of the hallux (HP:0010051) | 3.38584009 |
| 7 | Lip pit (HP:0100267) | 3.33392618 |
| 8 | Hyperacusis (HP:0010780) | 3.25566115 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.18927922 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 3.15915647 |
| 11 | Increased connective tissue (HP:0009025) | 3.10497789 |
| 12 | Short 4th metacarpal (HP:0010044) | 3.09429210 |
| 13 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.09429210 |
| 14 | Xanthomatosis (HP:0000991) | 3.02895975 |
| 15 | Hyperglycinemia (HP:0002154) | 3.01424097 |
| 16 | Overriding aorta (HP:0002623) | 3.00513386 |
| 17 | Distal lower limb amyotrophy (HP:0008944) | 2.99640738 |
| 18 | Elfin facies (HP:0004428) | 2.98339166 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 2.96681520 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.95048214 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.94157590 |
| 22 | Spinal rigidity (HP:0003306) | 2.86964770 |
| 23 | Hypoplastic labia majora (HP:0000059) | 2.86825827 |
| 24 | Peritonitis (HP:0002586) | 2.84202409 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72936716 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.72936716 |
| 27 | Esophageal varix (HP:0002040) | 2.68387190 |
| 28 | Abnormality of the diencephalon (HP:0010662) | 2.67946765 |
| 29 | Abnormality of the labia majora (HP:0012881) | 2.67501619 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.66722551 |
| 31 | Hyperammonemia (HP:0001987) | 2.66094397 |
| 32 | Achilles tendon contracture (HP:0001771) | 2.66025575 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.65434299 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65434299 |
| 35 | Abnormality of the 4th metacarpal (HP:0010012) | 2.62500690 |
| 36 | Hyperglycinuria (HP:0003108) | 2.62456338 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 2.60482580 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 2.58242076 |
| 39 | Insomnia (HP:0100785) | 2.57738271 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56350764 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 2.56034368 |
| 42 | Epidermoid cyst (HP:0200040) | 2.53506895 |
| 43 | Renal duplication (HP:0000075) | 2.52507408 |
| 44 | Hypolipoproteinemia (HP:0010981) | 2.51563080 |
| 45 | Protrusio acetabuli (HP:0003179) | 2.51059802 |
| 46 | Bladder diverticulum (HP:0000015) | 2.50721478 |
| 47 | Microglossia (HP:0000171) | 2.47687813 |
| 48 | Papillary thyroid carcinoma (HP:0002895) | 2.45358591 |
| 49 | Mitral valve prolapse (HP:0001634) | 2.43468791 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41332003 |
| 51 | Complement deficiency (HP:0004431) | 2.40353956 |
| 52 | Short nail (HP:0001799) | 2.38424518 |
| 53 | Ankle contracture (HP:0006466) | 2.38082221 |
| 54 | Aortic aneurysm (HP:0004942) | 2.36624851 |
| 55 | Spinal cord lesions (HP:0100561) | 2.35514965 |
| 56 | Syringomyelia (HP:0003396) | 2.35514965 |
| 57 | Natal tooth (HP:0000695) | 2.34806966 |
| 58 | Lower limb amyotrophy (HP:0007210) | 2.34752128 |
| 59 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.31344473 |
| 60 | Polycythemia (HP:0001901) | 2.31124830 |
| 61 | Myocardial infarction (HP:0001658) | 2.30833310 |
| 62 | Nemaline bodies (HP:0003798) | 2.29077283 |
| 63 | Vascular tortuosity (HP:0004948) | 2.26766200 |
| 64 | Hypoalphalipoproteinemia (HP:0003233) | 2.25714324 |
| 65 | Atrophic scars (HP:0001075) | 2.25220197 |
| 66 | Camptodactyly of toe (HP:0001836) | 2.25043990 |
| 67 | Fragile skin (HP:0001030) | 2.24294382 |
| 68 | Exercise-induced myalgia (HP:0003738) | 2.21455703 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.20819992 |
| 70 | Arterial tortuosity (HP:0005116) | 2.20784359 |
| 71 | Wormian bones (HP:0002645) | 2.20365435 |
| 72 | Cervical subluxation (HP:0003308) | 2.20227193 |
| 73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19172121 |
| 74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19172121 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19172121 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.19171434 |
| 77 | Shallow orbits (HP:0000586) | 2.18302553 |
| 78 | Enlarged penis (HP:0000040) | 2.18238804 |
| 79 | Bowel diverticulosis (HP:0005222) | 2.15910853 |
| 80 | Malnutrition (HP:0004395) | 2.15857525 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 2.11633256 |
| 82 | Muscle fiber inclusion bodies (HP:0100299) | 2.11205459 |
| 83 | Conjunctival hamartoma (HP:0100780) | 2.10990711 |
| 84 | Flat acetabular roof (HP:0003180) | 2.10586826 |
| 85 | Cerebral inclusion bodies (HP:0100314) | 2.10214119 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.10048725 |
| 87 | Back pain (HP:0003418) | 2.06881859 |
| 88 | Distal upper limb amyotrophy (HP:0007149) | 2.06861058 |
| 89 | Upper limb amyotrophy (HP:0009129) | 2.06861058 |
| 90 | Ketosis (HP:0001946) | 2.05468828 |
| 91 | Long clavicles (HP:0000890) | 2.03450928 |
| 92 | Macroorchidism (HP:0000053) | 2.03142115 |
| 93 | Difficulty climbing stairs (HP:0003551) | 2.03109654 |
| 94 | Asymmetric septal hypertrophy (HP:0001670) | 2.03069147 |
| 95 | Advanced eruption of teeth (HP:0006288) | 2.03000589 |
| 96 | Long palpebral fissure (HP:0000637) | 2.00973504 |
| 97 | Long toe (HP:0010511) | 2.00910935 |
| 98 | Hematochezia (HP:0002573) | 2.00536399 |
| 99 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00527880 |
| 100 | Cerebral aneurysm (HP:0004944) | 1.99905003 |
| 101 | Mitral regurgitation (HP:0001653) | 1.99828040 |
| 102 | Right ventricular cardiomyopathy (HP:0011663) | 1.99745517 |
| 103 | Polygenic inheritance (HP:0010982) | 1.99742179 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 1.99505418 |
| 105 | Intrahepatic cholestasis (HP:0001406) | 1.99263843 |
| 106 | Dilatation of the ascending aorta (HP:0005111) | 1.98070310 |
| 107 | Blue sclerae (HP:0000592) | 1.97912862 |
| 108 | Elbow flexion contracture (HP:0002987) | 1.94119111 |
| 109 | Chondrocalcinosis (HP:0000934) | 1.93430627 |
| 110 | Thin bony cortex (HP:0002753) | 1.92769064 |
| 111 | Broad face (HP:0000283) | 1.92074175 |
| 112 | Aortic dissection (HP:0002647) | 1.92032251 |
| 113 | Ulnar bowing (HP:0003031) | 1.91768857 |
| 114 | Acanthocytosis (HP:0001927) | 1.90888092 |
| 115 | Insidious onset (HP:0003587) | 1.90651366 |
| 116 | Termporal pattern (HP:0011008) | 1.90651366 |
| 117 | Hypercholesterolemia (HP:0003124) | 1.90494184 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.88489661 |
| 119 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88274900 |
| 120 | Abnormality of the thoracic spine (HP:0100711) | 1.88158662 |
| 121 | Disproportionate tall stature (HP:0001519) | 1.87962190 |
| 122 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87826879 |
| 123 | Generalized amyotrophy (HP:0003700) | 1.86123790 |
| 124 | Genu recurvatum (HP:0002816) | 1.85606148 |
| 125 | Chronic bronchitis (HP:0004469) | 1.84564476 |
| 126 | Facial hemangioma (HP:0000329) | 1.84092049 |
| 127 | Buphthalmos (HP:0000557) | 1.83489902 |
| 128 | Cellulitis (HP:0100658) | 1.83157702 |
| 129 | Asymmetry of the thorax (HP:0001555) | 1.82877536 |
| 130 | Upper motor neuron abnormality (HP:0002127) | 1.81803534 |
| 131 | Flat cornea (HP:0007720) | 1.81272245 |
| 132 | Ankyloglossia (HP:0010296) | 1.81169576 |
| 133 | Neurofibrillary tangles (HP:0002185) | 1.79678013 |
| 134 | Trismus (HP:0000211) | 1.79607461 |
| 135 | Increased nuchal translucency (HP:0010880) | 1.79196180 |
| 136 | Scapular winging (HP:0003691) | 1.78968455 |
| 137 | Spondylolisthesis (HP:0003302) | 1.77853543 |
| 138 | Abnormality of lateral ventricle (HP:0030047) | 1.77446147 |
| 139 | Amyloidosis (HP:0011034) | 1.77442111 |
| 140 | Neonatal death (HP:0003811) | 1.76068240 |
| 141 | Abnormality of the gastric mucosa (HP:0004295) | 1.75980116 |
| 142 | Lymphangioma (HP:0100764) | 1.75315043 |
| 143 | Persistence of primary teeth (HP:0006335) | 1.73875751 |
| 144 | Male infertility (HP:0003251) | 1.73543314 |
| 145 | Atrioventricular block (HP:0001678) | 1.73193484 |
| 146 | Abnormality of the acetabulum (HP:0003170) | 1.72913301 |
| 147 | Hypochromic microcytic anemia (HP:0004840) | 1.72344029 |
| 148 | Hyporeflexia of lower limbs (HP:0002600) | 1.71336835 |
| 149 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.70952811 |
| 150 | Abnormality of oral frenula (HP:0000190) | 1.70868783 |
| 151 | Dysmetric saccades (HP:0000641) | 1.70020357 |
| 152 | Exostoses (HP:0100777) | 1.69293401 |
| 153 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.68483505 |
| 154 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68430894 |
| 155 | Abnormality of nucleobase metabolism (HP:0010932) | 1.68204864 |
| 156 | Abnormality of the line of Schwalbe (HP:0008048) | 1.67394683 |
| 157 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66435119 |
| 158 | Abnormality of alanine metabolism (HP:0010916) | 1.66435119 |
| 159 | Hyperalaninemia (HP:0003348) | 1.66435119 |
| 160 | Progressive muscle weakness (HP:0003323) | 1.66169507 |
| 161 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.65796556 |
| 162 | Selective tooth agenesis (HP:0001592) | 1.65495633 |
| 163 | Anterior segment dysgenesis (HP:0007700) | 1.65353889 |
| 164 | Round ear (HP:0100830) | 1.65122401 |
| 165 | Spontaneous abortion (HP:0005268) | 1.64207943 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.63016145 |
| 167 | Abnormality of complement system (HP:0005339) | 1.62742731 |
| 168 | Aneurysm (HP:0002617) | 1.62688985 |
| 169 | Dysostosis multiplex (HP:0000943) | 1.62321959 |
| 170 | Nausea (HP:0002018) | 1.61287056 |
| 171 | Thoracic kyphosis (HP:0002942) | 1.60081084 |
| 172 | Spinal cord compression (HP:0002176) | 1.59903188 |
| 173 | Sacral dimple (HP:0000960) | 1.59600153 |
| 174 | Cupped ribs (HP:0000887) | 1.56142842 |
| 175 | Arnold-Chiari malformation (HP:0002308) | 1.54933458 |
| 176 | Abnormal ossification of hand bones (HP:0005921) | 1.54609794 |
| 177 | Sparse lateral eyebrow (HP:0005338) | 1.53716347 |
| 178 | Muscle stiffness (HP:0003552) | 1.53489017 |
| 179 | Hyperparathyroidism (HP:0000843) | 1.53019048 |
| 180 | Hand muscle atrophy (HP:0009130) | 1.50806657 |
| 181 | Axonal loss (HP:0003447) | 1.49681019 |
| 182 | Biconcave vertebral bodies (HP:0004586) | 1.49654139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.63784454 |
| 2 | MAP3K10 | 3.35657212 |
| 3 | PKN2 | 3.35157175 |
| 4 | PRPF4B | 3.21059819 |
| 5 | EEF2K | 3.14720433 |
| 6 | FRK | 2.94085211 |
| 7 | IRAK3 | 2.92255014 |
| 8 | SMG1 | 2.61848054 |
| 9 | NME2 | 2.27161292 |
| 10 | LATS1 | 2.26257061 |
| 11 | FGFR2 | 2.15454098 |
| 12 | LATS2 | 2.08986677 |
| 13 | EPHA3 | 2.03695685 |
| 14 | ACVR1B | 2.00857122 |
| 15 | FGFR4 | 1.90534479 |
| 16 | TAOK3 | 1.77968078 |
| 17 | STK38L | 1.74800689 |
| 18 | ARAF | 1.69337569 |
| 19 | KSR1 | 1.67412735 |
| 20 | MAP3K13 | 1.65266515 |
| 21 | PDK4 | 1.62989202 |
| 22 | PDK3 | 1.62989202 |
| 23 | TTN | 1.58115913 |
| 24 | LRRK2 | 1.55576068 |
| 25 | PTK2 | 1.41563341 |
| 26 | STK10 | 1.40558721 |
| 27 | BCKDK | 1.38994809 |
| 28 | FGFR3 | 1.37494266 |
| 29 | EPHB2 | 1.36959355 |
| 30 | DMPK | 1.35449152 |
| 31 | KSR2 | 1.30466272 |
| 32 | TTK | 1.27315757 |
| 33 | ERN1 | 1.26070525 |
| 34 | TAOK2 | 1.24677843 |
| 35 | STK3 | 1.24043028 |
| 36 | TAOK1 | 1.22695570 |
| 37 | RET | 1.22394577 |
| 38 | MAP2K3 | 1.20192381 |
| 39 | NEK9 | 1.19660430 |
| 40 | CDC7 | 1.18108474 |
| 41 | PDGFRA | 1.16668655 |
| 42 | PTK6 | 1.16003562 |
| 43 | PAK2 | 1.13081653 |
| 44 | TESK2 | 1.12737141 |
| 45 | ILK | 1.12588846 |
| 46 | NEK2 | 1.11118373 |
| 47 | NTRK1 | 1.10540635 |
| 48 | PDK2 | 1.10440543 |
| 49 | RIPK1 | 1.09071159 |
| 50 | EPHB1 | 1.07585036 |
| 51 | SIK1 | 1.07130400 |
| 52 | MAPKAPK3 | 1.05510112 |
| 53 | RAF1 | 1.04416662 |
| 54 | STK24 | 1.02861421 |
| 55 | MST1R | 0.99811096 |
| 56 | LIMK1 | 0.95369734 |
| 57 | PRKD3 | 0.93109869 |
| 58 | CDK6 | 0.92266793 |
| 59 | TESK1 | 0.91286274 |
| 60 | PAK4 | 0.89504216 |
| 61 | * MTOR | 0.87709809 |
| 62 | MAP3K14 | 0.86297338 |
| 63 | SIK3 | 0.85993777 |
| 64 | MET | 0.85906755 |
| 65 | CDK4 | 0.85758479 |
| 66 | MAP3K3 | 0.85304003 |
| 67 | EPHA2 | 0.82283200 |
| 68 | CDC42BPA | 0.81350484 |
| 69 | JAK3 | 0.81138012 |
| 70 | MOS | 0.79063552 |
| 71 | MAP3K6 | 0.78292300 |
| 72 | BRAF | 0.77167730 |
| 73 | RPS6KA4 | 0.76711354 |
| 74 | CDK9 | 0.76642008 |
| 75 | NEK1 | 0.74513129 |
| 76 | LMTK2 | 0.72386035 |
| 77 | CAMK1D | 0.71154252 |
| 78 | MELK | 0.70633491 |
| 79 | RPS6KB2 | 0.70254675 |
| 80 | PDGFRB | 0.69922673 |
| 81 | CSNK1A1L | 0.69157298 |
| 82 | TYK2 | 0.68267057 |
| 83 | PRKAA2 | 0.67127706 |
| 84 | MAPK11 | 0.67023376 |
| 85 | TYRO3 | 0.66937387 |
| 86 | PRKD2 | 0.66907073 |
| 87 | PBK | 0.66475334 |
| 88 | CAMK1G | 0.65943645 |
| 89 | TBK1 | 0.64950166 |
| 90 | PRKD1 | 0.64448742 |
| 91 | MAP3K8 | 0.62889464 |
| 92 | TGFBR2 | 0.62801250 |
| 93 | CLK1 | 0.62726686 |
| 94 | RPS6KA2 | 0.62636682 |
| 95 | TRPM7 | 0.60955127 |
| 96 | SCYL2 | 0.60547484 |
| 97 | MAP3K1 | 0.59812446 |
| 98 | DDR2 | 0.59187848 |
| 99 | FLT3 | 0.58789264 |
| 100 | ERBB4 | 0.58142049 |
| 101 | CDK7 | 0.55716401 |
| 102 | ERBB2 | 0.54785718 |
| 103 | PDPK1 | 0.54347484 |
| 104 | CSNK1G1 | 0.53646744 |
| 105 | MAP3K9 | 0.53231813 |
| 106 | FGFR1 | 0.53231236 |
| 107 | PRKAA1 | 0.53213011 |
| 108 | ROCK2 | 0.52683012 |
| 109 | MARK2 | 0.49987125 |
| 110 | ICK | 0.48632601 |
| 111 | IRAK2 | 0.48481111 |
| 112 | ABL2 | 0.48452104 |
| 113 | RPS6KC1 | 0.47895847 |
| 114 | RPS6KL1 | 0.47895847 |
| 115 | BMPR1B | 0.47601124 |
| 116 | DYRK2 | 0.47556600 |
| 117 | PIM2 | 0.47405738 |
| 118 | EGFR | 0.45932478 |
| 119 | MYLK | 0.45885920 |
| 120 | CHEK2 | 0.45335914 |
| 121 | BMX | 0.45323520 |
| 122 | PDK1 | 0.44747202 |
| 123 | SGK3 | 0.44206378 |
| 124 | IRAK4 | 0.44054514 |
| 125 | PLK3 | 0.43775048 |
| 126 | AKT2 | 0.43305383 |
| 127 | EIF2AK1 | 0.42364799 |
| 128 | RPS6KA1 | 0.42110443 |
| 129 | VRK1 | 0.42086282 |
| 130 | CDK12 | 0.42012602 |
| 131 | PRKG2 | 0.40845135 |
| 132 | NLK | 0.40013710 |
| 133 | CSNK1G3 | 0.39490438 |
| 134 | JAK1 | 0.39261649 |
| 135 | STK38 | 0.38876325 |
| 136 | AURKB | 0.37790934 |
| 137 | ALK | 0.37565317 |
| 138 | MAP3K11 | 0.37366733 |
| 139 | DYRK1B | 0.36004139 |
| 140 | MAPK12 | 0.35109197 |
| 141 | PAK1 | 0.34686075 |
| 142 | PAK3 | 0.34295585 |
| 143 | TGFBR1 | 0.34237295 |
| 144 | PRKCZ | 0.33579329 |
| 145 | DYRK3 | 0.33356710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27864490 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.20706268 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.64229237 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59571351 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39869777 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33144061 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16556705 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.08802980 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.05143292 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01122065 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91865538 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86850174 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81989946 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81052080 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.78794698 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76703477 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68406841 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66534517 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.62944907 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59252035 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58300219 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49940233 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47007313 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.46567546 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45909674 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40958167 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.40541209 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38401067 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38036217 |
| 30 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35202764 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34893522 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34448109 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28248967 |
| 34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27512230 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25010956 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24791764 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.22389824 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 1.21151945 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20881513 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19983308 |
| 41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17880821 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.17508848 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17314544 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16187867 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15638724 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14975928 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.14041980 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12150887 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10578875 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.08706453 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07263477 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.06048395 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05960184 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05900523 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04837302 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03701461 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03240144 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02775506 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02560538 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 1.02260781 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 1.01836237 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 1.01418568 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99939914 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99502792 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99155488 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.98891743 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93166515 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93115075 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92531862 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.92037988 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91627269 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.91542186 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91197575 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91195353 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90481550 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90386350 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89864971 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89310956 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87577316 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.86433070 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.85537441 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85489234 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85093549 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84333011 |
| 85 | Cell cycle_Homo sapiens_hsa04110 | 0.83117732 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82918789 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82892689 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82865626 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82865572 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82399551 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79920996 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.79893813 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79188143 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78891433 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78590181 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76810760 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75764912 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75551179 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74933983 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.74270926 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74235773 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74141434 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73927723 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73083028 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73010601 |
| 106 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71545066 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71160027 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70455678 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69864340 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69551334 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69092118 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67542001 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67419969 |
| 114 | DNA replication_Homo sapiens_hsa03030 | 0.66940559 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66823033 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66010189 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65951739 |
| 118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65644955 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65234585 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.64922580 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64694214 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64669184 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64493437 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61688357 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61630326 |
| 126 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61382202 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60861702 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60740681 |
| 129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60697981 |
| 130 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60635797 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59866332 |
| 132 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59759793 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58061479 |
| 134 | Measles_Homo sapiens_hsa05162 | 0.57459609 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56899155 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56644544 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56156512 |
| 138 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55291507 |
| 139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55261556 |
| 140 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55249513 |
| 141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55017399 |
| 142 | Tuberculosis_Homo sapiens_hsa05152 | 0.54647615 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54262584 |
| 144 | Gap junction_Homo sapiens_hsa04540 | 0.54101219 |
| 145 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52292078 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52038512 |
| 147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51949359 |
| 148 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51765253 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50891909 |
| 150 | Tight junction_Homo sapiens_hsa04530 | 0.50127600 |
| 151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49159375 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.48741462 |
| 153 | RNA degradation_Homo sapiens_hsa03018 | 0.48337466 |
| 154 | Prostate cancer_Homo sapiens_hsa05215 | 0.47250270 |
| 155 | ABC transporters_Homo sapiens_hsa02010 | 0.47146195 |
| 156 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46015793 |
| 157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45771040 |
| 158 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44671539 |
| 159 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44582541 |
| 160 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44536309 |
| 161 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44199773 |

